Abcam PLC
LSE:ABC

Watchlist Manager
Abcam PLC Logo
Abcam PLC
LSE:ABC
Watchlist
Price: 1 226 GBX 11.15%
Market Cap: 2.8B GBP

Operating Margin

0.1%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.1%
=
Operating Income
£30.5m
/
Revenue
£350.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.1%
=
Operating Income
GBX30.5m
/
Revenue
£350.4m

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Abcam PLC
LSE:ABC
2.8B GBP
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
382B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
160.4B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.4B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.6B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.2B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in United Kingdom
Percentile
50th
Based on 3 579 companies
50th percentile
0.1%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Abcam PLC
Glance View

Market Cap
2.8B GBX
Industry
Biotechnology

In the bustling realm of the life sciences, Abcam PLC has carved out a distinct niche as a leading provider of research tools and reagents that are fundamental to scientific discovery and innovation. Born in the vibrant academic environment of Cambridge, England, Abcam was founded in 1998 by Jonathan Milner and a small group of fellow scientists frustrated by the lack of quality and reliability in antibody products. The company’s vision was to fuel research globally by providing a reliable source of quality antibodies, knocking down barriers faced by researchers. From this germ of an idea grew Abcam’s expansive catalog, housing an impressive array of antibodies, proteins, reagents, and assays. These tools have become essential in the pursuit of breakthroughs in fields such as cancer research, drug development, and diagnostics. Abcam thrives on a business model that combines product innovation with an e-commerce platform that connects it to a global customer base of researchers and institutions. By meticulously validating the performance of their products, the company ensures that researchers can rely on the tools to deliver precise and reproducible results. This commitment to quality has fostered a level of trust that underpins the company’s growth. Abcam's revenues primarily stem from sales of its proprietary products alongside a curated selection from third-party vendors. The firm also invests significantly in understanding the evolving needs of the scientific community, tailoring its offerings to support cutting-edge research. This client-centric approach, coupled with their robust online presence, has facilitated Abcam’s expansion far beyond its roots, transforming it into a key player that supports scientific advancement globally.

ABC Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
0.1%
=
Operating Income
£30.5m
/
Revenue
£350.4m
How has Operating Margin changed over time?

Over the last 3 years, Abcam PLC’s Operating Margin has decreased from 0.3% to 0.1%. During this period, it reached a low of 0.1% on Jul 30, 2022 and a high of 0.3% on May 30, 2019.

Back to Top